Ambrilia Biopharma Provides Update on Reduction of Operations in France

Ambrilia announced that it has now implemented the major reduction of its activities in France, which resulted in the layoff of all the permanent employees based in France, including Dr. Bonabes de Rouge, Senior Executive Vice-President & Chief Scientific Officer of Ambrilia.
MSNBC